Form 4: Orthofix Medical Inc. CEO Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Orthofix Medical Inc.'s CEO, Massimo Calafiore, sold shares of common stock to cover tax withholding obligations related to the settlement of restricted stock units.
Summary
- On January 10, 2025, Massimo Calafiore, the President & CEO of Orthofix Medical Inc., sold 10,078 shares of common stock at a weighted average price of $16.8306.
- On January 13, 2025, Calafiore sold an additional 9,203 shares of common stock at a weighted average price of $17.1419.
- These sales were executed to satisfy tax withholding obligations related to the settlement of restricted stock units, as mandated by the Compensation and Talent Development Committee.
- Following these transactions, Calafiore directly owns 124,151 shares of common stock, which includes 94,057 restricted stock units.
Sentiment
Score: 6
Explanation: The sentiment is neutral. The document simply reports stock sales for tax obligations, which is a routine event. There are no indications of significant positive or negative implications for the company.
Positives
- The sales were pre-planned and mandated by the Compensation and Talent Development Committee, indicating a structured approach to executive compensation and tax obligations.
- The CEO still holds a significant number of shares (124,151), demonstrating continued investment in the company's success.
Future Outlook
There is no future outlook provided in this document.
Industry Context
Executive stock sales are a common occurrence, particularly to cover tax obligations related to equity compensation. The impact on the stock price is usually minimal if the sales are pre-planned and disclosed, as in this case.
Comparison to Industry Standards
- Executive compensation practices, including the use of restricted stock units and sell-to-cover arrangements, are standard across publicly traded companies.
- Companies like Medtronic, Stryker, and Johnson & Johnson also utilize similar equity compensation plans for their executives.
- The level of stock ownership maintained by the CEO after the sale is within a typical range for executives in comparable positions.
Stakeholder Impact
- The stock sales may have a minor, short-term impact on shareholders due to the increased supply of shares in the market.
- Employees are indirectly affected as the CEO's actions reflect the company's compensation policies and practices.
Key Dates
| Date | Description |
|---|---|
| 01/10/2025 | CEO sold 10,078 shares of common stock at a weighted average price of $16.8306. |
| 01/13/2025 | CEO sold 9,203 shares of common stock at a weighted average price of $17.1419. |
| 01/14/2025 | Date of signature for the Form 4 filing and Power of Attorney. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.